{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T16:26:30Z","timestamp":1777479990010,"version":"3.51.4"},"reference-count":53,"publisher":"SAGE Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CBM"],"published-print":{"date-parts":[[2020,5,29]]},"DOI":"10.3233\/cbm-190871","type":"journal-article","created":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T14:45:57Z","timestamp":1588949157000},"page":"255-268","source":"Crossref","is-referenced-by-count":28,"title":["Alterations of regulatory factors and DNA methylation pattern in thyroid cancer"],"prefix":"10.1177","volume":"28","author":[{"given":"Iulia V.","family":"Iancu","sequence":"first","affiliation":[{"name":"\u201cStefan S. Nicolau\u201d Institute of Virology, Bucharest, Romania"},{"name":"\u201cStefan S. Nicolau\u201d Institute of Virology, Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anca","family":"Botezatu","sequence":"additional","affiliation":[{"name":"\u201cStefan S. Nicolau\u201d Institute of Virology, Bucharest, Romania"},{"name":"\u201cStefan S. Nicolau\u201d Institute of Virology, Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana","family":"Plesa","sequence":"additional","affiliation":[{"name":"\u201cStefan S. Nicolau\u201d Institute of Virology, Bucharest, Romania"},{"name":"\u201cStefan S. Nicolau\u201d Institute of Virology, Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irina","family":"Huica","sequence":"additional","affiliation":[{"name":"\u201cStefan S. Nicolau\u201d Institute of Virology, Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alina","family":"Fudulu","sequence":"additional","affiliation":[{"name":"\u201cStefan S. Nicolau\u201d Institute of Virology, Bucharest, Romania"},{"name":"\u201cStefan S. Nicolau\u201d Institute of Virology, Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian","family":"Albulescu","sequence":"additional","affiliation":[{"name":"\u201cStefan S. Nicolau\u201d Institute of Virology, Bucharest, Romania"},{"name":"National Institute for Chemical Pharmaceutical Research and Development, Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marinela","family":"Bostan","sequence":"additional","affiliation":[{"name":"\u201cStefan S. Nicolau\u201d Institute of Virology, Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirela","family":"Mihaila","sequence":"additional","affiliation":[{"name":"\u201cStefan S. Nicolau\u201d Institute of Virology, Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camelia","family":"Grancea","sequence":"additional","affiliation":[{"name":"\u201cStefan S. Nicolau\u201d Institute of Virology, Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dana Alice","family":"Manda","sequence":"additional","affiliation":[{"name":"\u201cCI Parhon\u201d National Institute of Endocrinology, Bucharest, Romania"},{"name":"\u201cStefan S. Nicolau\u201d Institute of Virology, Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruxandra","family":"Dobrescu","sequence":"additional","affiliation":[{"name":"\u201cCI Parhon\u201d National Institute of Endocrinology, Bucharest, Romania"},{"name":"\u201cCarol Davila\u201d University of Medicine and Pharmacy, Bucharest, Romania"},{"name":"\u201cStefan S. Nicolau\u201d Institute of Virology, Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susana Vilma","family":"Vladoiu","sequence":"additional","affiliation":[{"name":"\u201cCI Parhon\u201d National Institute of Endocrinology, Bucharest, Romania"},{"name":"\u201cStefan S. Nicolau\u201d Institute of Virology, Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela","family":"Anton","sequence":"additional","affiliation":[{"name":"\u201cStefan S. Nicolau\u201d Institute of Virology, Bucharest, Romania"},{"name":"\u201cStefan S. Nicolau\u201d Institute of Virology, Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corin Virgil","family":"Badiu","sequence":"additional","affiliation":[{"name":"\u201cCI Parhon\u201d National Institute of Endocrinology, Bucharest, Romania"},{"name":"\u201cCarol Davila\u201d University of Medicine and Pharmacy, Bucharest, Romania"},{"name":"\u201cStefan S. Nicolau\u201d Institute of Virology, Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"key":"10.3233\/CBM-190871_ref2","unstructured":"R.V. Lloyd, R.Y. Osamura, G. Kloppel et al., WHO classification of tumours of endocrine organs. 4th edition. Lyon (France): IARC; 2017."},{"key":"10.3233\/CBM-190871_ref3","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1038\/modpathol.2010.129","article-title":"Papillary thyroid carcinoma: an update","volume":"24","author":"LiVolsi","year":"2011","journal-title":"Modern Pathol"},{"key":"10.3233\/CBM-190871_ref4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1385\/EP:13:1:03","article-title":"RET\/PTC rearrangement in thyroid tumors","volume":"13","author":"Nikiforov","year":"2002","journal-title":"Endocr Pathol"},{"key":"10.3233\/CBM-190871_ref5","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1677\/erc.1.0978","article-title":"BRAF mutation in thyroid cancer","volume":"12","author":"Xing","journal-title":"Endocr Relat Cancer"},{"key":"10.3233\/CBM-190871_ref6","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1530\/EJE-15-0605","article-title":"ENDOCRINE TUMOURS: Genetic predictors of thyroid cancer outcome","volume":"174","author":"Tavares","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"10.3233\/CBM-190871_ref7","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1002\/cncr.23869","article-title":"Association of PTEN gene methylation with genetic alterations in the phosphatidylinositol 3-kinase\/AKT signaling pathway in thyroid tumors","volume":"113","author":"Hou","year":"2008","journal-title":"Cancer"},{"key":"10.3233\/CBM-190871_ref8","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1126\/science.1210597","article-title":"Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine","volume":"333","author":"Ito","year":"2011","journal-title":"Science"},{"key":"10.3233\/CBM-190871_ref9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3892\/br.2014.375","article-title":"Epigenetic modifications in human thyroid cancer","volume":"3","author":"Faam","year":"2015","journal-title":"Biomed Rep"},{"key":"10.3233\/CBM-190871_ref10","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1002\/ijc.22110","article-title":"Association of aberrant methylation of tumor suppressor genes with tumor aggressiveness and BRAF mutation in papillary thyroid cancer","volume":"119","author":"Hu","year":"2006","journal-title":"Int J Cancer"},{"key":"10.3233\/CBM-190871_ref11","doi-asserted-by":"crossref","unstructured":"J. Mohammadi-asl, B. Larijani, Z. Khorgami et al., QualitativeandquantitativepromoterhypermethylationpatternsoftheP16,TSHR,RASSF1AandRAR, Med Oncol 28 (2011), 1123\u20131128.","DOI":"10.1007\/s12032-010-9587-z"},{"key":"10.3233\/CBM-190871_ref12","first-page":"861","article-title":"Gene-specific promoter hypermethylation without global hypomethylation in follicular thyroid cancer","volume":"33","author":"Lee","year":"2008","journal-title":"Int J Oncol"},{"issue":"1","key":"10.3233\/CBM-190871_ref13","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1089\/thy.2006.16.17","article-title":"PTEN promoter methylation in sporadic thyroid carcinomas","volume":"16","author":"Alvarez-Nu\u00f1ez","year":"2006","journal-title":"Thyroid"},{"issue":"1","key":"10.3233\/CBM-190871_ref14","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s00428-005-1268-5","article-title":"Global DNA methylation evaluation: potential complementary marker in differential diagnosis of thyroid neoplasia","volume":"447","author":"Galusca","year":"2005","journal-title":"Virchows Archiv"},{"key":"10.3233\/CBM-190871_ref15","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1101\/gad.276568.115","article-title":"Role of TET enzymes in DNA methylation, development, and cancer","volume":"30","author":"Rasmussen","year":"2016","journal-title":"Genes Dev"},{"key":"10.3233\/CBM-190871_ref16","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13072-015-0016-6","article-title":"Epigenetic regulatory functions of DNA modifications: 5-methylcytosine and beyond","volume":"8","author":"Breiling","year":"2015","journal-title":"Epigenet chromatin matin"},{"key":"10.3233\/CBM-190871_ref17","doi-asserted-by":"crossref","first-page":"e1002154","DOI":"10.1371\/journal.pgen.1002154","article-title":"Integrating 5-hydroxymethylcytosine into the epigenomic landscape of human embryonic stem cells","volume":"7","author":"Szulwach","year":"2011","journal-title":"PLOS Genetics"},{"key":"10.3233\/CBM-190871_ref18","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1186\/1471-2407-8-371","article-title":"Conventional and molecular cytogenetics of human non-medullary thyroid carcinoma: characterization of eight cell line models and review of the literature on clinical samples","volume":"8","author":"Ribeiro","year":"2008","journal-title":"BMC Cancer"},{"key":"10.3233\/CBM-190871_ref19","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.1210\/jc.2008-1102","article-title":"Deoxyribonucleic acid profiling analysis of 40 human thyroid cancer cell lines reveals cross-contamination resulting in cell line redundancy and misidentification","volume":"93","author":"Schweppe","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.3233\/CBM-190871_ref20","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1089\/thy.2007.0097","article-title":"Molecular and genotypic characterization of human thyroid follicular cell carcinoma-derived cell lines","volume":"17","author":"Meireles","year":"2007","journal-title":"Thyroid"},{"key":"10.3233\/CBM-190871_ref21","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S1387-2656(05)11004-7","article-title":"Tetrazolium dyes as tools in cell biology: new insights into their cellular reduction","volume":"11","author":"Berridge","year":"2005","journal-title":"Biotechnol Annu Rev"},{"key":"10.3233\/CBM-190871_ref22","first-page":"791","article-title":"Characterization of the tumor cells from human head and neck cancer","volume":"57","author":"Petric\u0103-Matei","year":"2016","journal-title":"Rom J Morphol Embryo"},{"key":"10.3233\/CBM-190871_ref23","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nprot.2006.458","article-title":"Live-cell assay for detection of apoptosis by dual-laser flow cytometry using Hoechst 33342 and 7-amino-actinomycin D","volume":"2","author":"Schmid","year":"2007","journal-title":"Nat Protoc"},{"key":"10.3233\/CBM-190871_ref24","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1038\/nprot.2006.238","article-title":"Analysis of apoptosis by propidium iodide staining and flow cytometry","volume":"1","author":"Riccardi","year":"2006","journal-title":"Nat Protoc"},{"key":"10.3233\/CBM-190871_ref25","first-page":"89","article-title":"Relative quantification. In Real-time PCR","author":"Pfaffl","year":"2007","journal-title":"Taylor & Francis"},{"key":"10.3233\/CBM-190871_ref26","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1093\/bioinformatics\/18.11.1427","article-title":"MethPrimer: designing primers for methylation PCRs","volume":"18","author":"Li","year":"2002","journal-title":"Bioinformatics"},{"key":"10.3233\/CBM-190871_ref27","doi-asserted-by":"crossref","first-page":"4442","DOI":"10.1158\/0008-5472.CAN-03-3341","article-title":"Quantitative multiplex methylation-specific PCR assay for the detection of promoter hypermethylation in multiple genes in breast cancer","volume":"64","author":"Fackler","year":"2004","journal-title":"Cancer Res"},{"key":"10.3233\/CBM-190871_ref28","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.bbrc.2012.12.034","article-title":"DNA methylation is associated with transcription of Snail and Slug genes","volume":"430","author":"Chen","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"10.3233\/CBM-190871_ref29","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1158\/1535-7163.MCT-13-0137","article-title":"Differential induction of apoptosis and senescence by the DNA methyltransferase inhibitors 5-azacytidine and 5-aza-2\u2019-deoxycytidine in solid tumor cells","volume":"12","author":"Venturelli","year":"2013","journal-title":"Mol Cancer Ther"},{"key":"10.3233\/CBM-190871_ref30","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/nrg2005","article-title":"Cancer epigenomics: DNA methylomes and histone-modification maps","volume":"8","author":"Esteller","year":"2007","journal-title":"Nat Rev Genet"},{"key":"10.3233\/CBM-190871_ref31","first-page":"1","article-title":"Methylation of tumour suppressor genes associated with thyroid cancer","author":"Botezatu","year":"2019","journal-title":"Cancer Biomarkers (Preprint)"},{"key":"10.3233\/CBM-190871_ref32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.mce.2017.07.012","article-title":"The epigenetic landscape of differentiated thyroid cancer","volume":"469","author":"Asa","year":"2018","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"10.3233\/CBM-190871_ref33","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s00428-005-1268-5","article-title":"Global DNA methylation evaluation: potential complementary marker in differential diagnosis of thyroid neoplasia","volume":"447","author":"Galusca","year":"2005","journal-title":"Virchows Archiv"},{"key":"10.3233\/CBM-190871_ref34","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s40618-015-0246-2","article-title":"Detection of global hypermethylation in well-differentiated thyroid neoplasms by immunohistochemical (5-methylcytidine) analysis","volume":"38","author":"Keelawat","year":"2015","journal-title":"J Endocrinol Invest"},{"key":"10.3233\/CBM-190871_ref35","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1210\/jc.2012-3566","article-title":"DNA methylation signatures identify biologically distinct thyroid cancer subtypes","volume":"98","author":"Rodr\u00edguez-Rodero","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.3233\/CBM-190871_ref36","doi-asserted-by":"crossref","first-page":"7360","DOI":"10.1158\/0008-5472.CAN-11-2023","article-title":"5-Hydroxymethylcytosine is strongly depleted in human cancers but its levels do not correlate with IDH1 mutations","volume":"71","author":"Jin","year":"2011","journal-title":"Cancer Res"},{"key":"10.3233\/CBM-190871_ref37","doi-asserted-by":"crossref","first-page":"23372","DOI":"10.18632\/oncotarget.4281","article-title":"TET family proteins and 5-hydroxymethylcytosine in esophageal squamous cell carcinoma","volume":"6","author":"Murata","year":"2015","journal-title":"Oncotarget"},{"key":"10.3233\/CBM-190871_ref38","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13148-016-0197-2","article-title":"5-Hydroxymethylcytosine discriminates between parathyroid adenoma and carcinoma","volume":"8","author":"Barazeghi","year":"2016","journal-title":"Clin Epigenetics"},{"key":"10.3233\/CBM-190871_ref39","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.cell.2012.07.033","article-title":"Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma","volume":"150(6)","author":"Lian","year":"2012","journal-title":"Cell"},{"key":"10.3233\/CBM-190871_ref40","doi-asserted-by":"crossref","first-page":"e41036","DOI":"10.1371\/journal.pone.0041036","article-title":"Decreased 5-hydroxymethylcytosine is associated with neural progenitor phenotype in normal brain and shorter survival in malignant glioma","volume":"7","author":"Orr","year":"2012","journal-title":"PLOS ONE"},{"key":"10.3233\/CBM-190871_ref41","doi-asserted-by":"crossref","first-page":"4837","DOI":"10.3892\/mmr.2015.4058","article-title":"Restored expression levels of TET1 decrease the proliferation and migration of renal carcinoma cells","volume":"12","author":"Fan","year":"2015","journal-title":"Mol Med Rep"},{"key":"10.3233\/CBM-190871_ref42","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1080\/00365521.2016.1253767","article-title":"Association of TET1 expression with colorectal cancer progression","volume":"52","author":"Tian","year":"2017","journal-title":"Scand J Gastroenterol"},{"key":"10.3233\/CBM-190871_ref43","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317695017","article-title":"Differential expression of ten-eleven translocation genes in endometrial cancers","volume":"39","author":"Ciesielski","year":"2017","journal-title":"Tumor Biol"},{"key":"10.3233\/CBM-190871_ref44","doi-asserted-by":"crossref","first-page":"e0133896","DOI":"10.1371\/journal.pone.0133896","article-title":"Reduced expression of TET1, TET2, TET3 and TDG mRNAs are associated with poor prognosis of patients with early breast cancer","volume":"10","author":"Yang","year":"2015","journal-title":"PLOS ONE"},{"key":"10.3233\/CBM-190871_ref45","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.7314\/APJCP.2015.16.3.1197","article-title":"Hypermethylation of TET1 promoter is a new diagnosic marker for breast cancer metastasis","volume":"16","author":"Sang","year":"2015","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.3233\/CBM-190871_ref46","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1158\/1940-6207.CAPR-14-0306","article-title":"Aberrant TET1 methylation closely associated with CpG island methylator phenotype in colorectal cancer","volume":"8","author":"Ichimura","year":"2015","journal-title":"Cancer Prev Res (Phila)"},{"issue":"9","key":"10.3233\/CBM-190871_ref47","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1111\/cas.12484","article-title":"TET2 as an epigenetic master regulator for normal and malignant hematopoiesis","volume":"105","author":"Nakajima","year":"2014","journal-title":"Cancer Sci"},{"key":"10.3233\/CBM-190871_ref48","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1101\/gad.260174.115","article-title":"Loss of TET2 in hematopoietic cells leads to DNA hypermethylation of active enhancers and induction of leukemogenesis","volume":"29","author":"Rasmussen","year":"2015","journal-title":"Genes Dev"},{"key":"10.3233\/CBM-190871_ref49","first-page":"3959","article-title":"TET2 promoter DNA methylation and expression in childhood acute lymphoblastic leukemia","volume":"17","author":"Bahari","year":"2016","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.3233\/CBM-190871_ref50","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1530\/ERC-17-0009","article-title":"A role for TET2 in parathyroid carcinoma","volume":"24","author":"Barazeghi","year":"2017","journal-title":"Endocr Relat Cancer"},{"key":"10.3233\/CBM-190871_ref51","doi-asserted-by":"crossref","first-page":"e369","DOI":"10.1038\/oncsis.2017.71","article-title":"Lysine demethylase KDM2A inhibits TET2 to promote DNA methylation and silencing of tumor suppressor genes in breast cancer","volume":"6","author":"Chen","year":"2017","journal-title":"Oncogenesis"},{"key":"10.3233\/CBM-190871_ref52","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature12362","article-title":"Vitamin C induces Tet-dependent DNA demethylation and a blastocyst-like state in ES cells","volume":"500","author":"Blaschke","year":"2013","journal-title":"Nature"},{"key":"10.3233\/CBM-190871_ref53","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13148-015-0087-z","article-title":"Epigenetic reprogramming of melanoma cells by vitamin C treatment","volume":"7","author":"Gustafson","year":"2015","journal-title":"Clin Epigenetics"},{"key":"10.3233\/CBM-190871_ref54","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13148-016-0213-6","article-title":"Vitamin C enhances epigenetic modifications induced by 5-azacytidine and cell cycle arrest in the hepatocellular carcinoma cell lines HLE and Huh7","volume":"8","author":"Sajadian","year":"2016","journal-title":"Clin Epigenetics"}],"container-title":["Cancer Biomarkers"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/CBM-190871","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:07:33Z","timestamp":1777385253000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/CBM-190871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,29]]},"references-count":53,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3233\/cbm-190871","relation":{},"ISSN":["1875-8592","1574-0153"],"issn-type":[{"value":"1875-8592","type":"electronic"},{"value":"1574-0153","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5,29]]}}}